General Updates

October 1, 2026 Listing Department Code: 532321 Listing Department Code: Zyduslife BSE Limited National Stock Exchange Of India Limited P J Towers, Dalal Street, Exchange Plaza, Bandra Kurla Complex, Fort, Mumbai-400001 Bandra (E), Mumbai-400051 Re.: Update on Investment in the equity shares of Zydus Sunshine Lifesciences (Private) Limited (“Zydus Sunshine”) Ref.: 1. Intimation under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Master Circular dated January 30, 2026 2. Our earlier intimation dated June 26, 2026 Dear Sir / Madam, In our earlier intimation dated June 26, 2026, Zydus Lifesciences Limited (“the Company”) intimated about execution of Share Subscription and Shareholders’ Agreement (“SSSHA”) with Sunshine Healthcare Lanka Limited (“Sunshine”) and Zydus Sunshine Lifesciences (Private) Limited (“Zydus Sunshine”) to subscribe 50% of the total paid-up equity share capital of Zydus Sunshine (“Subscription Shares”). It was also informed that post subscription of the Subscription Shares, Zydus Sunshine shall become a 50:50 joint venture of Zydus and Sunshine. This is to inform that Zydus and Sunshine are still in the process of completing condition precedents of the SSSHA. In view of the same, and as per the terms and conditions of the SSSHA, the Company and Sunshine have mutually decided to extend the date of closing. The Company and Sunshine have today, i.e. October 1, 2026, executed a letter to extend the date of completion as above. In view of the same, the transaction is expected to be completed by December 2026. Please take the above on record. Thanking you, Yours faithfully, For, Zydus Lifesciences Limited Dhaval N. Soni Company Secretary and Compliance Officer Membership No. FCSS7063